Cascadia Advisory Services’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Cascadia Advisory Services’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$1.91M	Buy	11,483 +305	+3%	+$52.1K	0.39%	92
2021 Q2	$1.93M	Sell	11,178 -11,388	-50%	-$1.88M	0.42%	91
2021 Q1	$3.62M	Buy	+22,566	New	+$3.86M	0.8%	33
2019 Q4	$370K	Buy	+2,486	New	+$341K	0.11%	157

Other funds holding FBT

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Cascadia Advisory Services's FBT Position: Q3 2021 in Review

Cascadia Advisory Services increased its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 2.7% in Q3 2021, buying an estimated $52.1K and bringing the position to 11,483 shares worth $1.91M. The position accounts for 0.39% of the portfolio, ranked #92.

Cascadia Advisory Services first reported a position in FBT in Q4 2019 and has held it in 4 quarters since. The position peaked at $3.62M in Q1 2021. 236 funds tracked by Wall St. Rank hold FBT as of Q3 2021.

Cascadia Advisory Services held 11,483 shares of First Trust NYSE Arca Biotechnology Index Fund worth $1.91M as of Q3 2021.
Cascadia Advisory Services bought 305 First Trust NYSE Arca Biotechnology Index Fund shares in Q3 2021, an estimated $52.1K.
First Trust NYSE Arca Biotechnology Index Fund made up 0.39% of Cascadia Advisory Services's portfolio in Q3 2021, its #92 holding.
Cascadia Advisory Services first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2019 and has held it in 4 quarters since.
Cascadia Advisory Services's First Trust NYSE Arca Biotechnology Index Fund position peaked at $3.62M in Q1 2021.
236 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q3 2021.

Based on Cascadia Advisory Services's 13F filing for Q3 2021, filed 12 Nov 2021.